Determination of aliskiren in human serum quantities by HPLC-tandem mass spectrometry appropriate for pediatric trials. - Wikidata - awgldk - TriplyDB

Determination of aliskiren in human serum quantities by HPLC-tandem mass spectrometry appropriate for pediatric trials.

Determination of aliskiren in human serum quantities by HPLC-tandem mass spectrometry appropriate for pediatric trials.

http://www.wikidata.org/entity/Q34440479

about

Liquid chromatography-tandem mass spectrometric assay for aliskiren, a novel renin inhibitor in micro-volumes of human plasma: a pharmacokinetic application in healthy South Indian male subjects.Simultaneous quantitative and qualitative analysis of aliskiren, enalapril and its active metabolite enalaprilat in undiluted human urine utilizing LC-ESI-MS/MS.Development and validation of a HPLC-PDA bioanalytical method for the simultaneous estimation of Aliskiren and Amlodipine in human plasma.Tailored Assays for Pharmacokinetic and Pharmacodynamic Investigations of Aliskiren and Enalapril in Children: An Application in Serum, Urine, and Saliva.

P2860

Q34708093-8F38AF4E-7C1A-4CE6-800F-929AFF6F8241 Q35161582-8B25BF49-D48E-4C0C-9263-3AFC4F01D446 Q35188590-522A71EA-115B-449A-B5B4-304081BCB932 Q36451684-DF5DB16E-9033-4327-9FC0-523BFB0B06A3

P2860

Determination of aliskiren in human serum quantities by HPLC-tandem mass spectrometry appropriate for pediatric trials.

http://www.wikidata.org/entity/Q34440479

description

2012 nî lūn-bûn

@nan

2012 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

Determination of aliskiren in ...... ropriate for pediatric trials.

@ast

Determination of aliskiren in ...... ropriate for pediatric trials.

@en

Determination of aliskiren in ...... ropriate for pediatric trials.

@nl

type

label

Determination of aliskiren in ...... ropriate for pediatric trials.

@ast

Determination of aliskiren in ...... ropriate for pediatric trials.

@en

Determination of aliskiren in ...... ropriate for pediatric trials.

@nl

prefLabel

Determination of aliskiren in ...... ropriate for pediatric trials.

@ast

Determination of aliskiren in ...... ropriate for pediatric trials.

@en

Determination of aliskiren in ...... ropriate for pediatric trials.

@nl

P1433

Q34440479-6AD29E3C-C913-4BDA-AF4B-71384FA4ACB5

P1476

Q34440479-45681F54-7DB1-4474-8C05-E58F70AC0B89

P2093

Q34440479-70F04BBD-E68C-422B-A54F-22B33DB1BDF6

Q34440479-C73F1887-00A8-406A-82DC-BE58469A3662

Q34440479-C7FC077E-B80B-4CA5-ADF4-2D768F11E38C

Q34440479-CABF61B6-9CE0-4054-8244-D4672AFCF310

P2860

Q34440479-003B83A6-0866-4789-931B-D04B4ADD7210

Q34440479-106E0333-919F-433A-BDAB-39734B1EE888

Q34440479-25FB6F2C-8DBF-4233-BFD1-F20661C10344

Q34440479-49CF45B7-F96B-4447-BC1E-24C61EE1C811

Q34440479-52C2F5EC-A510-4633-8C26-9A57C91120D5

Q34440479-717D97B9-9D90-4EFB-B3D4-BCC38BA34797

Q34440479-77B6ABD4-5FA3-4ADB-BAB5-33D2BDE04E5F

Q34440479-A66634AF-67CC-443B-9873-C5A5B5974513

P304

Q34440479-F2B594A5-28A5-4222-B4CD-C8A5268AF58F

P31

Q34440479-24769E54-D53D-46F8-9EA7-D969858C79CA

P356

Q34440479-80DDF6FD-ED60-4B62-B0AB-BAE72DC6565A

P433

Q34440479-9F254FBF-375F-4C24-AF2E-F6606590DC57

P478

Q34440479-D049660B-EB01-4302-9A64-888845C6588F

P577

Q34440479-050C8372-0739-44F7-ACB4-F8248AB4FB5C

P698

Q34440479-E1A83D4B-D185-41BA-9ABF-0299E8910DC8

P356

P1433

Biomedical Chromatography

P1476

Determination of aliskiren in ...... ropriate for pediatric trials.

@en

P2093

Bjoern B Burckhardt

http://www.w3.org/2001/XMLSchema#string

Jutta Tins

http://www.w3.org/2001/XMLSchema#string

Sergej Ramusovic

http://www.w3.org/2001/XMLSchema#string

Stephanie Laeer

http://www.w3.org/2001/XMLSchema#string

P2860

Orange and apple juice greatly reduce the plasma concentrations of the OATP2B1 substrate aliskiren.

Matrix effects: the Achilles heel of quantitative high-performance liquid chromatography-electrospray-tandem mass spectrometry.

Pharmacokinetics of the oral direct renin inhibitor aliskiren in combination with digoxin, atorvastatin, and ketoconazole in healthy subjects: the role of P-glycoprotein in the disposition of aliskiren.

Pharmacokinetics of the oral direct renin inhibitor aliskiren alone and in combination with irbesartan in renal impairment.

Effect of ABCB1 haplotypes on the pharmacokinetics and renin-inhibiting effect of aliskiren.

A study of the pharmacokinetic interactions of the direct renin inhibitor aliskiren with metformin, pioglitazone and fenofibrate in healthy subjects.

Strategies for the assessment of matrix effect in quantitative bioanalytical methods based on HPLC-MS/MS.

Itraconazole, a P-Glycoprotein and CYP3A4 Inhibitor, Markedly Raises the Plasma Concentrations and Enhances the Renin-Inhibiting Effect of Aliskiren

P304

477-486

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/BMC.2815

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

27

http://www.w3.org/2001/XMLSchema#string

P577

2012-10-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23055424

http://www.w3.org/2001/XMLSchema#string